W. Zoli

D. Amadori, D. Calistri, L. Saragoni, 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity

D. Amadori, A. Sparatore, A. Tesei, 2012, Journal of cellular physiology.

Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome

A. Tesei, R. Silvestrini, M. Falconi, 2014, Molecular and Cellular Endocrinology.

Comparison between differentcell kinetic variables in human breast cancer

E. Scarpi, D. Amadori, A. Volpi, 2000 .

Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models

D. Amadori, A. Tesei, C. Leonetti, 2009, Journal of cellular and molecular medicine.

Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer

E. Scarpi, D. Amadori, S. Carloni, 2012, Tumori.

Phase II trial of non-pegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer.

E. Scarpi, D. Amadori, S. Carloni, 2012, Tumori.

Amplification of the pericentromeric region of chromosome 1 in a newly established colon carcinoma cell line.

E. Giulotto, W. Zoli, L. Bertoni, 2003, Cancer genetics and cytogenetics.

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: A single center study

E. Scarpi, D. Amadori, D. Calistri, 2012, Journal of Translational Medicine.

Isolation of stem/progenitor cells from normal lung tissue of adult humans

D. Amadori, A. Tesei, M. Rosetti, 2009, Cell proliferation.

CYP17A1 Polymorphisms and Clinical Outcome of Castration-Resistant Prostate Cancer Patients Treated with Abiraterone

V. Conteduca, U. de Giorgi, S. Salvi, 2016, The International journal of biological markers.

Discrepancies between VEGF −1154 G>A Polymorphism Analysis Performed in Peripheral Blood Samples and FFPE Tissue

D. Amadori, D. Calistri, P. Ulivi, 2014, International journal of molecular sciences.

Innovative sequence of docetaxel-gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study.

D. Amadori, A. Tesei, T. Ibrahim, 2005, Lung cancer.

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

O. Nanni, D. Amadori, C. Dazzi, 2008, Journal of Translational Medicine.

Gene copy number variation in male breast cancer by aCGH

S. Tommasi, A. Paradiso, P. Chiarappa, 2011, Cellular Oncology.

EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab

E. Scarpi, D. Amadori, D. Calistri, 2015, Oncology letters.

KRAS, BRAF and PIK3CA Status in Squamous Cell Anal Carcinoma (SCAC)

E. Scarpi, D. Amadori, L. Capelli, 2014, PloS one.

Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients.

E. Scarpi, D. Amadori, Yibin Kang, 2011, Clinical breast cancer.

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

E. Scarpi, D. Amadori, T. Ibrahim, 2011, Oncology.

A new cell line from human infiltrating ductal carcinoma of the breast: establishment and characterization

D. Amadori, N. Zini, A. Sensi, 2005, Journal of Cancer Research and Clinical Oncology.

Molecular genetics and in vitro sensitivity of a new human cell line, KKP, from a gastric adenocarcinoma.

D. Amadori, N. Zini, D Amadori, 1998, Cancer genetics and cytogenetics.

Cyto-morphological aspects and cyto-histological correlations in pre-neoplastic alterations and in malignancies of gastric mucosa

D. Amadori, W. Zoli, A. Ravaioli, 1981, Acta Endoscopica.

Perspectives on mTOR inhibitors for castration-refractory prostate cancer.

D. Amadori, U. de Giorgi, F. Fabbri, 2012, Current cancer drug targets.

Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches

D. Amadori, R. Silvestrini, W. Zoli, 2011, Journal of Clinical Pathology.

Predictive Role of Telomerase Activity in the Clinical Outcome of Patients with Benign Lesions of the Uterine Cervix or CIN

E. Scarpi, R. Silvestrini, W. Zoli, 2012, Analytical Cellular Pathology.

Assessment of DNA Damage and Telomerase Activity in Exfoliated Urinary Cells as Sensitive and Noninvasive Biomarkers for Early Diagnosis of Bladder Cancer in Ex-Workers of a Rubber Tyres Industry

D. Calistri, S. Iavicoli, E. Pira, 2014, BioMed research international.

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients.

D. Amadori, D. Calistri, R. Silvestrini, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Role of biological markers in the clinical outcome of colon cancer

O. Nanni, E. Scarpi, D. Amadori, 2002, British Journal of Cancer.

Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype.

S. Cocchi, W. Zoli, L. Roncuzzi, 2002, Cancer genetics and cytogenetics.

Copy Number Analysis of 24 Oncogenes: MDM4 Identified as a Putative Marker for Low Recurrence Risk in Non Muscle Invasive Bladder Cancer

D. Calistri, G. Gurioli, S. Salvi, 2014, International journal of molecular sciences.

In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.

M. Dietel, M. Aapro, B. Hill, 1994, Anticancer research.

Doxorubicin, Paclitaxel and Gemcitabine: a Phase I Study of a New Sequential Treatment in Stage III B - IV Breast Cancer

D. Amadori, T. Ibrahim, W. Zoli, 2003, Journal of chemotherapy.

Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid

D. Amadori, A. Tesei, P. Ulivi, 2012, Cancer Cell International.

Flow-Cytometric Determination of Tumor Cells in Lymph Nodes1

D. Amadori, A. Tesei, W. Zoli, 2002, Oncology.

SLUG silencing increases radiosensitivity of melanoma cells in vitro

A. Tesei, R. Silvestrini, P. Ulivi, 2012, Cellular Oncology.

In vitro schedule-dependent interaction between docetaxel and gemcitabine in human gastric cancer cell lines.

D. Amadori, A. Tesei, P. Ulivi, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Schedule‐dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines

D. Amadori, W. Zoli, G. Frassineti, 1999, International journal of cancer.

Lanreotide-Induced Modulation of 5-Fluorouracil or Mitomycin C Cytotoxicity in Human Colon Cancer Cell Lines: a Preclinical Study

A. Tesei, W. Zoli, G. Frassineti, 2000, Journal of chemotherapy.

Peripheral Blood miR-328 Expression as a Potential Biomarker for the Early Diagnosis of NSCLC

E. Scarpi, D. Amadori, R. Silvestrini, 2013, International journal of molecular sciences.

Potentiation of Antiproliferative Drug Activity by Lonidamine in Hepatocellular Carcinoma Cells

D. Amadori, A. Tesei, P. Ulivi, 2003, Journal of chemotherapy.

Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines

Anna Tesei, Wainer Zoli, Dino Amadori, 2005, Breast Cancer Research.

[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines.

Wainer Zoli, Dino Amadori, Chiara Liverani, 2013, International journal of oncology.

In vitro potentiation by lonidamine of the cytotoxic effect of adriamycin on primary and established breast cancer cell lines

O. Nanni, D. Amadori, A. Volpi, 2005, Breast Cancer Research and Treatment.

Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines.

Anna Tesei, Wainer Zoli, Alice Pasini, 2012, Translational oncology.

Free DNA and Carcinoembryonic Antigen Serum Levels: An Important Combination for Diagnosis of Colorectal Cancer

O. Nanni, D. Amadori, D. Calistri, 2006, Clinical Cancer Research.

Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.

D. Amadori, A. Tesei, V. Poletti, 2012, International journal of oncology.

Establishment and characterization of a new cell line from primary human breast carcinoma

D. Amadori, E. Giulotto, W. Zoli, 2004, Breast Cancer Research and Treatment.

IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia

D. Amadori, G. Martinelli, S. Carloni, 2015, Journal of Translational Medicine.

Cell kinetics and hormonal features in relation to pathological stage in breast cancer

O. Nanni, D. Amadori, C. Bonaguri, 1991, Breast Cancer Research and Treatment.

Cell kinetics and prognosis in gastric cancer

O. Nanni, D. Amadori, A. Volpi, 1993, Cancer.

Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer.

E. Ferrazzí, A. Perin, W. Zoli, 2006, Gynecologic oncology.

EGFR and K-ras mutations in cytologic samples from fine-needle aspirates in NSCLC patients

P. Candoli, D. Calistri, R. Silvestrini, 2012, European Respiratory Journal.

Modulation of drug cytotoxicity by iressa (ZD1839) in pancreatic cancer cell lines

D. Amadori, A. Tesei, P. Ulivi, 2005, Cancer biology & therapy.

Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study

Wainer Zoli, Francesco Fabbri, S. Carloni, 2006, BMC Cell Biology.

Docetaxel–ST1481 sequence exerts a potent cytotoxic activity on hormone‐resistant prostate cancer cells by reducing drug resistance‐related gene expression

D. Amadori, A. Tesei, R. Silvestrini, 2009, The Prostate.

Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line

D. Amadori, A. Tesei, R. Silvestrini, 2008, Journal of Translational Medicine.

Pro-apoptotic activity of cyclopentenone in cancer cells.

A. Tesei, M. Rosetti, C. Arienti, 2008, Anticancer research.

Bone metastases detection by circulating biomarkers: OPG and RANK-L.

E. Scarpi, D. Amadori, Yibin Kang, 2011, International journal of oncology.

Activity of endovesical gemcitabine in BCG-refractory bladder cancer patients: a translational study

O. Nanni, R. Silvestrini, P. Ulivi, 2007, British Journal of Cancer.

Schedule-Dependent Cytotoxic Interaction between Epidoxorubicin and Gemcitabine in Human Bladder Cancer Cells in Vitro

D. Amadori, A. Tesei, P. Ulivi, 2004, Clinical Cancer Research.

Comparison between different cell kinetic variables in human breast cancer.

E. Scarpi, D. Amadori, A. Volpi, 2000, Cell proliferation.

Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics

D. Amadori, A. Tesei, R. Silvestrini, 2007, Journal of cellular physiology.

Mitotic catastrophe and apoptosis induced by docetaxel in hormone‐refractory prostate cancer cells

D. Amadori, A. Tesei, R. Silvestrini, 2008, Journal of cellular physiology.

Activity of different anthracycline formulations in hormone‐refractory prostate cancer cell lines: Role of golgi apparatus

D. Amadori, A. Tesei, R. Silvestrini, 2011, Journal of cellular physiology.

Modulating effect of lonidamine on response to doxorubicin in metastatic breast cancer patients: Results from a multicenter prospective randomized trial

O. Nanni, E. Scarpi, D. Amadori, 1998, Breast Cancer Research and Treatment.

RANK/RANK-L/OPG in Patients with Bone Metastases Treated with Anticancer Agents and Zoledronic Acid: A Prospective Study

E. Scarpi, D. Amadori, M. Ricci, 2013, International journal of molecular sciences.

Fecal DNA for Noninvasive Diagnosis of Colorectal Cancer in Immunochemical Fecal Occult Blood Test–Positive Individuals

E. Scarpi, D. Amadori, D. Calistri, 2010, Cancer Epidemiology, Biomarkers & Prevention.

Improving reliability of live/dead cell counting through automated image mosaicing

Alessandro Bevilacqua, Filippo Piccinini, Anna Tesei, 2014, Comput. Methods Programs Biomed..

New Biomarkers to Predict the Evolution of In Situ Breast Cancers

E. Scarpi, D. Amadori, R. Silvestrini, 2014, BioMed research international.

Biofunctional characteristics of in situ and invasive breast carcinoma

D. Amadori, R. Silvestrini, S. Folli, 2013, Cellular Oncology.

SLUG silencing increases radiosensitivity of melanoma cells in vitro

A. Tesei, R. Silvestrini, P. Ulivi, 2013, Cellular Oncology.

In vitro irradiation system for radiobiological experiments

A. Tesei, R. Silvestrini, M. Falconi, 2013, Radiation oncology.

Image processing method for 3D volume rendering from one 2D projection: Application to Cancer spheroids

Alessandro Bevilacqua, Filippo Piccinini, Anna Tesei, 2014, 2014 4th International Conference on Image Processing Theory, Tools and Applications (IPTA).

DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach

D. Amadori, D. Calistri, R. Silvestrini, 2013, Journal of experimental & clinical cancer research : CR.

NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.

D. Amadori, A. Tesei, C. Leonetti, 2008, Nitric oxide : biology and chemistry.

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells

D. Amadori, A. Tesei, P. Ulivi, 2005, Apoptosis.

First evidence of a large CHEK2 duplication involved in cancer predisposition in an Italian family with hereditary breast cancer

D. Amadori, D. Calistri, F. Falcini, 2014, BMC Cancer.

ALK translocation detection in non‐small cell lung cancer cytological samples obtained by TBNA or EBUS‐TBNA

D. Amadori, P. Candoli, D. Calistri, 2016, Cytopathology : official journal of the British Society for Clinical Cytology.

Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines

D. Amadori, A. Tesei, P. Ulivi, 2007, Journal of Translational Medicine.